New paper
TEMPORAL TRENDS IN PANCREATIC CANCER MORTALITY IN BRAZIL BETWEEN 1980 AND 2023: ARE WE ALIGNED WITH THE GLOBAL PROJECTIONS?
Why it was picked newest record on or before this date
The Pancreatic Cancer Research Digest
New trials, papers and changes to existing records, compiled daily from the public registries
New paper
Impact of CYP2A6 Genotype on Survival Outcomes in Patients With Pancreatic Ductal Adenocarcinoma Receiving Perioperative S-1 Therapy.
Why it was picked newest record on or before this date
New paper
AI-driven tumor heterogeneity quantification and survival prediction in pancreatic ductal adenocarcinoma.
Why it was picked newest record on or before this date
New paper
A comprehensive proteomic dataset of secretomes from primary pancreatic cancer cell cultures.
Why it was picked newest record on or before this date
New paper
Clinical benefit of locoregional therapy for oligometastasis after surgery for pancreatic cancer: a single center retrospective study.
Why it was picked newest record on or before this date
Also today
New paper
Tumor-intrinsic Ist1 restricts IFNγ responsiveness to drive immune evasion in pancreatic cancer
New paper
Treatment patterns and outcomes of patients with a diagnosis of metastatic pancreatic adenocarcinoma in the United States, 2019-2024.
New paper
Integrating Network Toxicology with Molecular Dynamics Simulations to Reveal Key Targets and Binding Mechanisms of Bisphenol A in Pancreatic Ductal Adenocarcinoma.
New paper
Mechanobiology-guided drug repurposing identifies budesonide as an inhibitor of stiffness-induced PDAC aggressiveness
Change tracking began 4 November 2026, after this day, so only its new records are listed.
Compiled by the knowledge layer from its change log. Every headline opens the underlying record; every identifier links to its source.